title: Systematic review: Very-low-strength evidence suggests that combining ezetimibe or fibrate with statins is no more effective than high-dose statin monotherapy for reducing all-cause mortality.
authors.affiliation: Sackler Faculty of Medicine, Tel-Aviv University, Israel. altenen@post.tau.ac.il
authors.forename: Alexander
authors.initials: A
authors.lastname: Tenenbaum
authors.forename: Enrique Z
authors.initials: EZ
authors.lastname: Fisman